AEGON to Delist from Tokyo Stock Exchange

THE HAGUE, Netherlands, January 18  /PRNewswire-FirstCall/ -- AEGON will make an application to delist its common shares from the Tokyo Stock Exchange.

The volume of AEGON shares traded on the Tokyo Stock Exchange is negligible and does not justify the related expenses.

AEGON shares will continue to be listed on Euronext Amsterdam, the New York Stock Exchange and the London Stock Exchange.

About AEGON

As an international life insurance, pension and investment company based in The Hague, AEGON has businesses in over twenty markets in the Americas, Europe and Asia. AEGON companies employ approximately 29,000 people and have over 40 million customers across the globe.

                                         Full year
  Key figures - EUR           Q3 2009         2008
  Underlying earnings
  before tax              351 million  1.6 billion
  New life sales          484 million  2.6 billion
  Gross deposits          6.8 billion 40.8 billion
  Revenue generating
  investments
  (end of period)         354 billion  332 billion


  Forward-looking statements


The statements contained in this press release that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to our company. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. We undertake no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

  - Changes in general economic conditions, particularly in the United
    States, the Netherlands and the United Kingdom;

  - Changes in the performance of financial markets, including emerging
    markets, such as with regard to:

     - The frequency and severity of defaults by issuers in our fixed
       income investment portfolios; and

     - The effects of corporate bankruptcies and/or accounting restatements
       on the financial markets and the resulting decline in the value of
       equity and debt securities we hold;

  - The frequency and severity of insured loss events;

  - Changes affecting mortality, morbidity and other factors that may
    impact the profitability of our insurance products;

  - Changes affecting interest rate levels and continuing low or rapidly
    changing interest rate levels;

  - Changes affecting currency exchange rates, in particular the EUR/USD
    and EUR/GBP exchange rates;

  - Increasing levels of competition in the United States, the Netherlands,
    the United Kingdom and emerging markets;

  - Changes in laws and regulations, particularly those affecting our
    operations, the products we sell, and the attractiveness of certain
    products to our consumers;

  - Regulatory changes relating to the insurance industry in the
    jurisdictions in which we operate;

  - Acts of God, acts of terrorism, acts of war and pandemics;

  - Effects of deliberations of the European Commission regarding the aid
    we received from the Dutch State in December 2008;

  - Changes in the policies of central banks and/or governments;

  - Lowering of one or more of our debt ratings issued by recognized rating
    organizations and the adverse impact such action may have on our
    ability to raise capital and on our liquidity and financial condition;

  - Lowering of one or more of insurer financial strength ratings of our
    insurance subsidiaries and the adverse impact such action may have on
    the premium writings, policy retention, profitability of its insurance
    subsidiaries and liquidity;

  - Litigation or regulatory action that could require us to pay
    significant damages or change the way we do business;

  - Customer responsiveness to both new products and distribution channels;

  - Competitive, legal, regulatory, or tax changes that affect the
    distribution cost of or demand for our products;

  - The impact of acquisitions and divestitures, restructurings, product
    withdrawals and other unusual items, including our ability to integrate
    acquisitions and to obtain the anticipated results and synergies from
    acquisitions;

  - Our failure to achieve anticipated levels of earnings or operational
    efficiencies as well as other cost saving initiatives; and

  - The impact our adoption of the International Financial Reporting
    Standards may have on our reported financial results and financial
    condition.



Further details of potential risks and uncertainties affecting the company are described in the company's filings with Euronext Amsterdam and the US Securities and Exchange Commission, including the Annual Report on Form 20-F. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

  Contact information

  Media relations: Greg Tucker
  [phone]
  

  Investor relations: Gerbrand Nijman
  [phone]

  877-548-9668 - toll free USA only

  

  http://www.aegon.com/

DATASOURCE: AEGON N.V.



CONTACT:  Contact information: Media relations: Greg Tucker,

[phone],  ; Investor relations: Gerbrand Nijman,

[phone], 877-548-9668 - toll free USA only, 

Copyright